Cargando…
Cdc25 and Wee1: analogous opposites?
Movement through the cell cycle is controlled by the temporally and spatially ordered activation of cyclin-dependent kinases paired with their respective cyclin binding partners. Cell cycle events occur in a stepwise fashion and are monitored by molecular surveillance systems to ensure that each cel...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1868713/ https://www.ncbi.nlm.nih.gov/pubmed/17480229 http://dx.doi.org/10.1186/1747-1028-2-12 |
_version_ | 1782133387614486528 |
---|---|
author | Perry, Jennifer A Kornbluth, Sally |
author_facet | Perry, Jennifer A Kornbluth, Sally |
author_sort | Perry, Jennifer A |
collection | PubMed |
description | Movement through the cell cycle is controlled by the temporally and spatially ordered activation of cyclin-dependent kinases paired with their respective cyclin binding partners. Cell cycle events occur in a stepwise fashion and are monitored by molecular surveillance systems to ensure that each cell cycle process is appropriately completed before subsequent events are initiated. Cells prevent entry into mitosis while DNA replication is ongoing, or if DNA is damaged, via checkpoint mechanisms that inhibit the activators and activate the inhibitors of mitosis, Cdc25 and Wee1, respectively. Once DNA replication has been faithfully completed, Cdc2/Cyclin B is swiftly activated for a timely transition from interphase into mitosis. This sharp transition is propagated through both positive and negative feedback loops that impinge upon Cdc25 and Wee1 to ensure that Cdc2/Cyclin B is fully activated. Recent reports from a number of laboratories have revealed a remarkably complex network of kinases and phosphatases that coordinately control Cdc25 and Wee1, thereby precisely regulating the transition into mitosis. Although not all factors that inhibit Cdc25 have been shown to activate Wee1 and vice versa, a number of regulatory modules are clearly shared in common. Thus, studies on either the Cdc25 or Wee1-regulatory arm of the mitotic control pathway should continue to shed light on how both arms are coordinated to smoothly regulate mitotic entry. |
format | Text |
id | pubmed-1868713 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-18687132007-05-15 Cdc25 and Wee1: analogous opposites? Perry, Jennifer A Kornbluth, Sally Cell Div Review Movement through the cell cycle is controlled by the temporally and spatially ordered activation of cyclin-dependent kinases paired with their respective cyclin binding partners. Cell cycle events occur in a stepwise fashion and are monitored by molecular surveillance systems to ensure that each cell cycle process is appropriately completed before subsequent events are initiated. Cells prevent entry into mitosis while DNA replication is ongoing, or if DNA is damaged, via checkpoint mechanisms that inhibit the activators and activate the inhibitors of mitosis, Cdc25 and Wee1, respectively. Once DNA replication has been faithfully completed, Cdc2/Cyclin B is swiftly activated for a timely transition from interphase into mitosis. This sharp transition is propagated through both positive and negative feedback loops that impinge upon Cdc25 and Wee1 to ensure that Cdc2/Cyclin B is fully activated. Recent reports from a number of laboratories have revealed a remarkably complex network of kinases and phosphatases that coordinately control Cdc25 and Wee1, thereby precisely regulating the transition into mitosis. Although not all factors that inhibit Cdc25 have been shown to activate Wee1 and vice versa, a number of regulatory modules are clearly shared in common. Thus, studies on either the Cdc25 or Wee1-regulatory arm of the mitotic control pathway should continue to shed light on how both arms are coordinated to smoothly regulate mitotic entry. BioMed Central 2007-05-04 /pmc/articles/PMC1868713/ /pubmed/17480229 http://dx.doi.org/10.1186/1747-1028-2-12 Text en Copyright © 2007 Perry and Kornbluth; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Perry, Jennifer A Kornbluth, Sally Cdc25 and Wee1: analogous opposites? |
title | Cdc25 and Wee1: analogous opposites? |
title_full | Cdc25 and Wee1: analogous opposites? |
title_fullStr | Cdc25 and Wee1: analogous opposites? |
title_full_unstemmed | Cdc25 and Wee1: analogous opposites? |
title_short | Cdc25 and Wee1: analogous opposites? |
title_sort | cdc25 and wee1: analogous opposites? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1868713/ https://www.ncbi.nlm.nih.gov/pubmed/17480229 http://dx.doi.org/10.1186/1747-1028-2-12 |
work_keys_str_mv | AT perryjennifera cdc25andwee1analogousopposites AT kornbluthsally cdc25andwee1analogousopposites |